PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128330
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 2128330
Male Infertility Market Size, Share, Growth, Global Industry Analysis, Regional Insights and Forecast to 2026-2034
Growth Factors of male infertility Market
The global male infertility market was valued at USD 793.6 million in 2025 and is projected to grow from USD 844.8 million in 2026 to USD 1,372.3 million by 2034, registering a CAGR of 6.3% during the forecast period (2026-2034). The market is experiencing steady growth due to increasing infertility prevalence, delayed parenthood, growing awareness of male reproductive health, and the expansion of fertility diagnostic services worldwide. In 2025, North America dominated the global market with a 35.53% share, supported by advanced fertility care infrastructure, greater awareness, and widespread adoption of specialized infertility diagnostics.
Male infertility refers to a male partner's inability to contribute to conception due to factors such as low sperm count, poor sperm motility, abnormal sperm morphology, hormonal disorders, DNA fragmentation, oxidative stress, reproductive tract obstruction, and other fertility-related conditions. The market encompasses diagnostic technologies, laboratory testing, clinical evaluation services, and fertility care pathways designed to identify and manage male reproductive disorders.
Growing Shift Toward Evidence-Based Male Fertility Evaluation
One of the most important trends shaping the male infertility market is the transition from basic fertility assessment to structured, evidence-based diagnostic pathways. Historically, fertility investigations primarily focused on women, while male evaluation often occurred later in the treatment journey. However, clinical guidelines now recommend early evaluation of both partners, resulting in greater utilization of semen analysis, reproductive history assessment, hormonal testing, genetic screening, and advanced diagnostic procedures.
The increasing adoption of data-driven fertility care, specialized andrology services, and standardized laboratory protocols is improving diagnostic accuracy and enabling personalized treatment planning. Fertility centers are also expanding dedicated male fertility programs, transforming male infertility into a distinct healthcare segment rather than a secondary component of reproductive medicine.
Rising Infertility Burden Driving Market Growth
The increasing global burden of infertility is one of the primary drivers of market expansion. According to international health organizations, infertility affects a significant portion of the population, creating substantial demand for fertility testing and treatment services.
Growing awareness that infertility is not exclusively a female health issue has encouraged more men to seek evaluation and treatment. Additionally, increasing assisted reproductive technology (ART) procedures continue to expand the patient pool requiring male fertility assessment. As more couples pursue fertility treatments, male partners are increasingly entering formal diagnostic pathways, driving demand for advanced fertility testing services.
Social Stigma and Limited Access Restrict Market Growth
Despite rising awareness, several barriers continue to limit market expansion. In many countries, fertility evaluation remains expensive and concentrated within urban private healthcare facilities, restricting access for a large segment of the population.
Social stigma surrounding male infertility also remains a significant challenge. Many men delay or avoid testing due to embarrassment, misconceptions, or cultural beliefs that primarily associate infertility with women. Furthermore, reimbursement limitations and inconsistent use of advanced diagnostic tests across healthcare systems continue to affect adoption rates.
Another challenge is the complexity of male infertility diagnosis. A considerable number of cases remain unexplained despite extensive testing, making treatment planning difficult and limiting confidence in some advanced diagnostic procedures.
Advanced Diagnostic Technologies Creating Growth Opportunities
The strongest opportunity within the market lies in the increasing adoption of advanced diagnostic testing beyond conventional semen analysis. Fertility specialists are increasingly utilizing sperm DNA fragmentation testing, oxidative stress analysis, genetic evaluations, and computer-assisted semen analysis (CASA) to obtain a more comprehensive understanding of male reproductive health.
Modern fertility centers are investing in digital imaging systems, automated laboratory workflows, and advanced andrology services to improve diagnostic accuracy and consistency. Emerging markets also present significant growth potential as awareness improves and fertility services expand beyond major metropolitan areas.
As fertility care becomes increasingly personalized, advanced diagnostics are expected to play a larger role in identifying underlying causes of infertility and guiding treatment decisions.
Segment Analysis
Based on technique, the market is segmented into DNA fragmentation testing, oxidative stress analysis, microscopic examination, sperm penetration assay, sperm agglutination, computer-assisted semen analysis, and others. The microscopic examination segment dominated the market in 2025, as conventional semen analysis remains the primary diagnostic tool used worldwide for evaluating sperm count, motility, morphology, and semen volume.
The computer-assisted semen analysis (CASA) segment is projected to grow at the fastest rate, registering a CAGR of 8.2% through 2034, driven by increasing demand for automated and standardized fertility assessments.
By condition type, primary male infertility accounted for the largest market share in 2025 and is projected to hold 70.1% of the market in 2026. The dominance of this segment is attributed to the high number of couples seeking fertility evaluation while attempting conception for the first time. Secondary male infertility is expected to grow at a CAGR of 7.0% during the forecast period.
Based on end user, hospitals and clinics dominated the market in 2025 and are expected to account for 58.2% of market share in 2026. These facilities serve as primary centers for fertility consultation, semen analysis, diagnostic evaluation, and treatment planning. The diagnostic laboratories segment is projected to grow at a CAGR of 7.4% through 2034.
Regional Outlook
North America remained the leading regional market, reaching USD 282.0 million in 2025. The region benefits from strong fertility awareness, a large network of fertility clinics, and widespread use of advanced reproductive diagnostic technologies. The U.S. market is expected to reach USD 271.4 million in 2026, accounting for approximately 32.1% of global revenue.
Europe is projected to reach USD 269.2 million in 2026, growing at a CAGR of 5.8%. The region's growth is supported by well-established fertility care networks, structured reproductive medicine programs, and strong clinician awareness.
Asia Pacific is forecast to reach USD 209.2 million in 2026, driven by large patient populations, increasing fertility awareness, delayed parenthood trends, and expanding fertility services in countries such as China, Japan, South Korea, Australia, and India. China is expected to generate USD 58.9 million in revenue in 2026, while India is projected to contribute USD 34.0 million.
Competitive Landscape
The male infertility market is moderately fragmented, with leading companies focusing on semen analysis systems, advanced diagnostic technologies, oxidative stress testing, and sperm DNA fragmentation analysis. Major market participants include Hamilton Thorne, Inc., Medical Electronic Systems (MES), CooperSurgical, Inc., Bonraybio Co., Ltd., Halotech DNA S.L., PROiSER R+D S.L., Sperm Processor Pvt. Ltd., Nidacon International AB, FertiPro N.V., and MiOXSYS.
Recent industry developments include Medical Electronic Systems' launch of MaleMan semen analysis services in July 2025, Fellow Health's USD 24 million Series B funding, and collaborative studies supporting wider adoption of oxidative stress testing technologies.
Conclusion
The global male infertility market is expected to expand from USD 793.6 million in 2025 to USD 844.8 million in 2026, ultimately reaching USD 1,372.3 million by 2034. Rising infertility prevalence, growing acceptance of male fertility evaluation, increasing use of advanced diagnostics, and expanding fertility care infrastructure will continue to drive market growth. Although social stigma, reimbursement limitations, and diagnostic complexity remain challenges, ongoing technological advancements and greater awareness of male reproductive health are expected to create significant opportunities for long-term market expansion.
Segmentation By Techniques, Condition Type, End-user, and Region
By Techniques * DNA Fragmentation Technique
- Oxidative Stress Analysis
- Microscopic Examination
- Sperm Penetration Assay
- Sperm Agglutination
- Computer Assisted Semen Analysis
- Others
By Condition Type * Primary Male Infertility
- Secondary Male Infertility
By End-user * Hospitals and Clinics
- Diagnostic Laboratories
- Others
By Region * North America (By Techniques, By Condition Type, By End-user, and By Country)
- U.S. (By Condition Type)
- Canada (By Condition Type)
- Europe (By Techniques, By Condition Type, By End-user, and By Country/Sub-region)
- Germany (By Condition Type)
- U.K. (By Condition Type)
- France (By Condition Type)
- Spain (By Condition Type)
- Italy (By Condition Type)
- Scandinavia (By Condition Type)
- Rest of Europe (By Condition Type)
- Asia Pacific (By Techniques, By Condition Type, By End-user, and By Country/Sub-region)
- China (By Condition Type)
- Japan (By Condition Type)
- India (By Condition Type)
- Australia (By Condition Type)
- Southeast Asia (By Condition Type)
- Rest of Asia Pacific (By Condition Type)
- Latin America (By Techniques, By Condition Type, By End-user, and By Country/Sub-region)
- Brazil (By Condition Type)
- Mexico (By Condition Type)
- Rest of Latin America (By Condition Type)
- Middle East & Africa (By Techniques, By Condition Type, By End-user, and By Country/Sub-region)
- GCC (By Condition Type)
- South Africa (By Condition Type)
- Rest of the Middle East & Africa (By Condition Type)
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Challenges
- 3.5. Market Trends
4. Key Insights
- 4.1. Advancements in Male Infertility
- 4.2. New Product Launchers
- 4.3. Key Industry Developments - (Mergers, Acquisitions & Partnerships, and Others)
5. Global Male Infertility Market Analysis, Insights and Forecast, 2021-2034
- 5.1. Market Analysis, Insights and Forecast - By Techniques
- 5.1.1. DNA Fragmentation Technique
- 5.1.2. Oxidative Stress Analysis
- 5.1.3. Microscopic Examination
- 5.1.4. Sperm Penetration Assay
- 5.1.5. Sperm Agglutination
- 5.1.6. Computer Assisted Semen Analysis
- 5.1.7. Others
- 5.2. Market Analysis, Insights and Forecast - By Condition Type
- 5.2.1. Primary Male Infertility
- 5.2.2. Secondary Male Infertility
- 5.3. Market Analysis, Insights and Forecast - By End-user
- 5.3.1. Hospitals and Clinics
- 5.3.2. Diagnostic Laboratories
- 5.3.3. Others
- 5.4. Market Analysis, Insights and Forecast - By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America
- 5.4.5. Middle East & Africa
6. North America Male Infertility Market Analysis, Insights and Forecast, 2021-2034
- 6.1. Market Analysis, Insights and Forecast - By Techniques
- 6.1.1. DNA Fragmentation Technique
- 6.1.2. Oxidative Stress Analysis
- 6.1.3. Microscopic Examination
- 6.1.4. Sperm Penetration Assay
- 6.1.5. Sperm Agglutination
- 6.1.6. Computer Assisted Semen Analysis
- 6.1.7. Others
- 6.2. Market Analysis, Insights and Forecast - By Condition Type
- 6.2.1. Primary Male Infertility
- 6.2.2. Secondary Male Infertility
- 6.3. Market Analysis, Insights and Forecast - By End-user
- 6.3.1. Hospitals and Clinics
- 6.3.2. Diagnostic Laboratories
- 6.3.3. Others
- 6.4. Market Analysis, Insights and Forecast - By Country
- 6.4.1. U.S.
- 6.4.1.1. By Condition Type
- 6.4.2. Canada
- 6.4.2.1. By Condition Type
- 6.4.1. U.S.
7. Europe Male Infertility Market Analysis, Insights and Forecast, 2021-2034
- 7.1. Market Analysis, Insights and Forecast - By Techniques
- 7.1.1. DNA Fragmentation Technique
- 7.1.2. Oxidative Stress Analysis
- 7.1.3. Microscopic Examination
- 7.1.4. Sperm Penetration Assay
- 7.1.5. Sperm Agglutination
- 7.1.6. Computer Assisted Semen Analysis
- 7.1.7. Others
- 7.2. Market Analysis, Insights and Forecast - By Condition Type
- 7.2.1. Primary Male Infertility
- 7.2.2. Secondary Male Infertility
- 7.3. Market Analysis, Insights and Forecast - By End-user
- 7.3.1. Hospitals and Clinics
- 7.3.2. Diagnostic Laboratories
- 7.3.3. Others
- 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 7.4.1. Germany
- 7.4.1.1. By Condition Type
- 7.4.2. U.K.
- 7.4.2.1. By Condition Type
- 7.4.3. France
- 7.4.3.1. By Condition Type
- 7.4.4. Italy
- 7.4.4.1. By Condition Type
- 7.4.5. Spain
- 7.4.5.1. By Condition Type
- 7.4.6. Scandinavia
- 7.4.6.1. By Condition Type
- 7.4.7. Rest of Europe
- 7.4.7.1. By Condition Type
- 7.4.1. Germany
8. Asia Pacific Male Infertility Market Analysis, Insights and Forecast, 2021-2034
- 8.1. Market Analysis, Insights and Forecast - By Techniques
- 8.1.1. DNA Fragmentation Technique
- 8.1.2. Oxidative Stress Analysis
- 8.1.3. Microscopic Examination
- 8.1.4. Sperm Penetration Assay
- 8.1.5. Sperm Agglutination
- 8.1.6. Computer Assisted Semen Analysis
- 8.1.7. Others
- 8.2. Market Analysis, Insights and Forecast - By Condition Type
- 8.2.1. Primary Male Infertility
- 8.2.2. Secondary Male Infertility
- 8.3. Market Analysis, Insights and Forecast - By End-user
- 8.3.1. Hospitals and Clinics
- 8.3.2. Diagnostic Laboratories
- 8.3.3. Others
- 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 8.4.1. China
- 8.4.1.1. By Condition Type
- 8.4.2. India
- 8.4.2.1. By Condition Type
- 8.4.3. Japan
- 8.4.3.1. By Condition Type
- 8.4.4. Australia
- 8.4.4.1. By Condition Type
- 8.4.5. Southeast Asia
- 8.4.5.1. By Condition Type
- 8.4.6. Rest of Asia Pacific
- 8.4.6.1. By Condition Type
- 8.4.1. China
9. Latin America Male Infertility Market Analysis, Insights and Forecast, 2021-2034
- 9.1. Market Analysis, Insights and Forecast - By Techniques
- 9.1.1. DNA Fragmentation Technique
- 9.1.2. Oxidative Stress Analysis
- 9.1.3. Microscopic Examination
- 9.1.4. Sperm Penetration Assay
- 9.1.5. Sperm Agglutination
- 9.1.6. Computer Assisted Semen Analysis
- 9.1.7. Others
- 9.2. Market Analysis, Insights and Forecast - By Condition Type
- 9.2.1. Primary Male Infertility
- 9.2.2. Secondary Male Infertility
- 9.3. Market Analysis, Insights and Forecast - By End-user
- 9.3.1. Hospitals and Clinics
- 9.3.2. Diagnostic Laboratories
- 9.3.3. Others
- 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 9.4.1. Brazil
- 9.4.1.1. By Condition Type
- 9.4.2. Mexico
- 9.4.2.1. By Condition Type
- 9.4.3. Rest of Latin America
- 9.4.3.1. By Condition Type
- 9.4.1. Brazil
10. Middle East & Africa Male Infertility Market Analysis, Insights and Forecast, 2021-2034
- 10.1. Market Analysis, Insights and Forecast - By Techniques
- 10.1.1. DNA Fragmentation Technique
- 10.1.2. Oxidative Stress Analysis
- 10.1.3. Microscopic Examination
- 10.1.4. Sperm Penetration Assay
- 10.1.5. Sperm Agglutination
- 10.1.6. Computer Assisted Semen Analysis
- 10.1.7. Others
- 10.2. Market Analysis, Insights and Forecast - By Condition Type
- 10.2.1. Primary Male Infertility
- 10.2.2. Secondary Male Infertility
- 10.3. Market Analysis, Insights and Forecast - By End-user
- 10.3.1. Hospitals and Clinics
- 10.3.2. Diagnostic Laboratories
- 10.3.3. Others
- 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
- 10.4.1. South Africa
- 10.4.1.1. By Condition Type
- 10.4.2. GCC
- 10.4.2.1. By Condition Type
- 10.4.3. Rest of the Middle East & Africa
- 10.4.3.1. By Condition Type
- 10.4.1. South Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2025)
- 11.2. Company Profiles
- 11.2.1. Hamilton Thorne, Inc.
- 11.2.2. Medical Electronic Systems (MES)
- 11.2.3. CooperSurgical, Inc.
- 11.2.4. Bonraybio Co., Ltd.
- 11.2.5. Halotech DNA, S.L.
- 11.2.6. PROiSER R+D, S.L.
- 11.2.7. Sperm Processor Pvt. Ltd.
- 11.2.8. Nidacon International AB
- 11.2.9. FertiPro N.V.
- 11.2.10. MiOXSYS
List of Tables
- Table 1: Global Male Infertility Market Revenue (USD Million) Forecast, By Techniques, 2021-2034
- Table 2: Global Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 3: Global Male Infertility Market Revenue (USD Million) Forecast, by End-user 2021-2034
- Table 4: Global Male Infertility Market Revenue (USD Million) Forecast, by Region, 2021-2034
- Table 5: North America Male Infertility Market Revenue (USD Million) Forecast, By Techniques, 2021-2034
- Table 6: North America Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 7: North America Male Infertility Market Revenue (USD Million) Forecast, by End-user 2021-2034
- Table 8: North America Male Infertility Market Revenue (USD Million) Forecast, By Country, 2021-2034
- Table 9: U.S. Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 10: Canada Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 11: Europe Male Infertility Market Revenue (USD Million) Forecast, By Techniques, 2021-2034
- Table 12: Europe Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 13: Europe Male Infertility Market Revenue (USD Million) Forecast, by End-user 2021-2034
- Table 14: Europe Male Infertility Market Revenue (USD Million) Forecast, By Country/ Sub-region, 2021-2034
- Table 15: Germany Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 16: U.K. Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 17: France Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 18: Italy Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 19: Spain Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 20: Scandinavia Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 21: Rest of Europe Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 22: Asia Pacific Male Infertility Market Revenue (USD Million) Forecast, By Techniques, 2021-2034
- Table 23: Asia Pacific Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 24: Asia Pacific Male Infertility Market Revenue (USD Million) Forecast, by End-user 2021-2034
- Table 25: Asia Pacific Male Infertility Market Revenue (USD Million) Forecast, By Country/ Sub-region, 2021-2034
- Table 26: China Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 27: India Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 28: Japan Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 29: Australia Pacific Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 30: Southeast Asia Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 31: Rest of Asia Pacific Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 32: Latin America Male Infertility Market Revenue (USD Million) Forecast, By Techniques, 2021-2034
- Table 33: Latin America Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 34: Latin America Male Infertility Market Revenue (USD Million) Forecast, by End-user 2021-2034
- Table 35: Latin America Male Infertility Market Revenue (USD Million) Forecast, By Country/ Sub-region, 2021-2034
- Table 36: Brazil Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 37: Mexico Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 38: Rest of Latin America Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 39: Middle East & Africa Male Infertility Market Revenue (USD Million) Forecast, Products & Service Type, 2021-2034
- Table 40: Middle East & Africa Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 41: Middle East & Africa Male Infertility Market Revenue (USD Million) Forecast, by End-user 2021-2034
- Table 42: Middle East & Africa Male Infertility Market Revenue (USD Million) Forecast, By Country/ Sub-region, 2021-2034
- Table 43: GCC Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 44: South Africa Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
- Table 45: Rest of the Middle East & Africa Male Infertility Market Revenue (USD Million) Forecast, By Condition Type, 2021-2034
List of Figures
- Figure 1: Global Male Infertility Market Revenue Breakdown (USD Million, %) by Region, 2025 & 2034
- Figure 2: Global Male Infertility Market Value Share (%), By Techniques, 2025 & 2034
- Figure 3: Global Male Infertility Market Value Share (%), By Condition Type, 2025 & 2034
- Figure 4: Global Male Infertility Market Value Share (%), by End-user, 2025 & 2034
- Figure 5: Global Male Infertility Market Value (USD Million), by Region, 2025 & 2034
- Figure 6: North America Male Infertility Market Value (USD Million), By Techniques, 2025 & 2034
- Figure 7: North America Male Infertility Market Value Share (%), By Techniques, 2025
- Figure 8: North America Male Infertility Market Value (USD Million), By Condition Type, 2025 & 2034
- Figure 9: North America Male Infertility Market Value Share (%), By Condition Type, 2025
- Figure 10: North America Male Infertility Market Value (USD Million), by End-user, 2025 & 2034
- Figure 11: North America Male Infertility Market Value Share (%), by End-user, 2025
- Figure 12: North America Male Infertility Market Value (USD Million), By Country, 2025 & 2034
- Figure 13: North America Male Infertility Market Value Share (%), By Country, 2025
- Figure 14: Europe Male Infertility Market Value (USD Million), By Techniques, 2025 & 2034
- Figure 15: Europe Male Infertility Market Value Share (%), By Techniques, 2025
- Figure 16: Europe Male Infertility Market Value (USD Million), By Condition Type, 2025 & 2034
- Figure 17: Europe Male Infertility Market Value Share (%), By Condition Type, 2025
- Figure 18: Europe Male Infertility Market Value (USD Million), by End-user, 2025 & 2034
- Figure 19: Europe Male Infertility Market Value Share (%), by End-user, 2025
- Figure 20: Europe Male Infertility Market Value (USD Million), By Country/Sub-region, 2025 & 2034
- Figure 21: Europe Male Infertility Market Value Share (%), By Country/Sub-region, 2025
- Figure 22: Asia Pacific Male Infertility Market Value (USD Million), By Techniques, 2025 & 2034
- Figure 23: Asia Pacific Male Infertility Market Value Share (%), By Techniques, 2025
- Figure 24: Asia Pacific Male Infertility Market Value (USD Million), By Condition Type, 2025 & 2034
- Figure 25: Asia Pacific Male Infertility Market Value Share (%), By Condition Type, 2025
- Figure 26: Asia Pacific Male Infertility Market Value (USD Million), by End-user, 2025 & 2034
- Figure 27: Asia Pacific Male Infertility Market Value Share (%), by End-user, 2025
- Figure 28: Asia Pacific Male Infertility Market Value (USD Million), By Country/Sub-region, 2025 & 2034
- Figure 29: Asia Pacific Male Infertility Market Value Share (%), By Country/Sub-region, 2025
- Figure 30: Latin America Male Infertility Market Value (USD Million), By Techniques, 2025 & 2034
- Figure 31: Latin America Male Infertility Market Value Share (%), By Techniques, 2025
- Figure 32: Latin America Male Infertility Market Value (USD Million), By Condition Type, 2025 & 2034
- Figure 33: Latin America Male Infertility Market Value Share (%), By Condition Type, 2025
- Figure 34: Latin America Male Infertility Market Value (USD Million), by End-user, 2025 & 2034
- Figure 35: Latin America Male Infertility Market Value Share (%), by End-user, 2025
- Figure 36: Latin America Male Infertility Market Value (USD Million), By Country/Sub-region, 2025 & 2034
- Figure 37: Latin America Male Infertility Market Value Share (%), By Country/Sub-region, 2025
- Figure 38: Middle East & Africa Male Infertility Market Value (USD Million), By Techniques, 2025 & 2034
- Figure 39: Middle East & Africa Male Infertility Market Value Share (%), By Techniques, 2025
- Figure 41: Middle East & Africa Male Infertility Market Value (USD Million), By Condition Type, 2025 & 2034
- Figure 42: Middle East & Africa Male Infertility Market Value Share (%), By Condition Type, 2025
- Figure 43: Middle East & Africa Male Infertility Market Value (USD Million), by End-user, 2025 & 2034
- Figure 44: Middle East & Africa Male Infertility Market Value Share (%), by End-user, 2025
- Figure 45: Middle East & Africa Male Infertility Market Value (USD Million), By Country/Sub-region, 2025 & 2034
- Figure 46: Middle East & Africa Male Infertility Market Value Share (%), By Country/Sub-region, 2025
- Figure 47: Global Male Infertility Market Share (%), By Company, 2025
